KC
CLBTW

Kepos Capital’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Kepos Capital’s Portfolio CLBTW Stock Details CLBTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-66,666
Closed -$143K – 690
2021
Q3 		$143K Buy
+66,666
New +$153K 0.01% 504

Other funds holding CLBTW

GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CPM
Crescent Park Management East Palo Alto, California $29M AUM 1.79% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Kepos Capital's CLBTW Position: Q4 2021 in Review

Kepos Capital sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q4 2021, closing a stake of 66,666 shares — an estimated $143K sold.

Kepos Capital first reported a position in CLBTW in Q3 2021 and held it in 1 quarter. The position peaked at $143K in Q3 2021. 31 funds tracked by Wall St. Rank hold CLBTW as of Q4 2021.

  • Kepos Capital reported no remaining Cellebrite DI Ltd. Warrants position as of Q4 2021 after selling out during the quarter.
  • Kepos Capital sold 66,666 Cellebrite DI Ltd. Warrants shares in Q4 2021, an estimated $143K.
  • Kepos Capital first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 1 quarter.
  • Kepos Capital's Cellebrite DI Ltd. Warrants position peaked at $143K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q4 2021.

Based on Kepos Capital's 13F filing for Q4 2021, filed 14 Feb 2022.